This multi-action mechanism helps manage blood glucose while promoting weight loss, setting Tirzepatide apart from other GLP-1 agonists that target only the GLP-1 pathway
10.1016/j.prp.2018.12.013 99 TanS.LiR.DingK.LobieP
The Diabetes Prevention Programme, a large RCT comparing Metformin, ILI and placebo, indicated that after 21 years of follow-up, there was no significant reduction in cancer incidence comparing ILI to placebo (RR 0.96, 95% CI = 0.791.18) [14]
Never share your pen with others, even if the needle is changed, as this risks transmission of infection
The BCBS FEP program, which covers federal employees, generally offers the most comprehensive weight loss medication coverage within the BCBS system
We also confirmed that the excitatory effect of exendin-4 on neurons in the IML region (4 preganglionic neurons and 1 interneurons) was blocked by GLP-1 receptor antagonist (1015 min pretreatment of antagonist followed by 100 nM exendin-4 plus antagonist) (Fig